ProfileGDS4718 / 237145_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 27% 23% 16% 30% 14% 44% 36% 22% 27% 11% 17% 19% 28% 38% 27% 35% 6% 40% 31% 32% 14% 29% 21% 23% 25% 21% 28% 13% 18% 26% 42% 59% 18% 20% 23% 36% 25% 13% 15% 14% 30% 19% 14% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4276227
GSM549102patient 115, normal, homogenized [OPG study]4.2668523
GSM549104patient 119, normal, homogenized [OPG study]3.9752416
GSM549108patient 138, normal, homogenized [OPG study]4.5813230
GSM549119patient 077, normal, homogenized [OPG study]3.9211214
GSM549133patient 032, cancer, homogenized [OPG study]5.1076944
GSM549139patient 042, cancer, homogenized [OPG study]4.7796836
GSM549099patient 107, normal, homogenized [OPG study]4.2392422
GSM549109patient 139, normal, homogenized [OPG study]4.4502427
GSM549110patient 046, normal, homogenized [OPG study]3.8040611
GSM549114patient 063, normal, homogenized [OPG study]4.0006517
GSM549122patient 082, normal, homogenized [OPG study]4.1007919
GSM549134patient 033, cancer, homogenized [OPG study]4.4456228
GSM549136patient 036, cancer, homogenized [OPG study]4.8202938
GSM549140patient 044, cancer, homogenized [OPG study]4.3745527
GSM549111patient 047, normal, homogenized [OPG study]4.7273235
GSM549113patient 057, normal, homogenized [OPG study]3.614046
GSM549132patient 031, cancer, homogenized [OPG study]4.9625440
GSM549137patient 038, cancer, homogenized [OPG study]4.58231
GSM549142patient 047, cancer, homogenized [OPG study]4.7282232
GSM549100patient 110, normal, homogenized [OPG study]3.9438814
GSM549107patient 135, normal, homogenized [OPG study]4.4776529
GSM549115patient 068, normal, homogenized [OPG study]4.1314321
GSM549116patient 072, normal, homogenized [OPG study]4.2534923
GSM549120patient 078, normal, homogenized [OPG study]4.3148725
GSM549131patient 030, cancer, homogenized [OPG study]4.1377821
GSM549118patient 074, normal, homogenized [OPG study]4.444328
GSM549129patient 027, cancer, homogenized [OPG study]3.9102513
GSM549123patient 088, normal, homogenized [OPG study]4.0717618
GSM549124patient 006, cancer, homogenized [OPG study]4.4341126
GSM549126patient 015, cancer, homogenized [OPG study]5.0765742
GSM549128patient 025, cancer, homogenized [OPG study]6.0817459
GSM549103patient 117, normal, homogenized [OPG study]4.1246618
GSM549117patient 073, normal, homogenized [OPG study]4.139820
GSM549138patient 041, cancer, homogenized [OPG study]4.2290723
GSM549141patient 045, cancer, homogenized [OPG study]4.7320336
GSM549130patient 028, cancer, homogenized [OPG study]4.3670125
GSM549101patient 111, normal, homogenized [OPG study]3.9056813
GSM549105patient 128, normal, homogenized [OPG study]3.9638115
GSM549106patient 134, normal, homogenized [OPG study]3.8880314
GSM549112patient 048, normal, homogenized [OPG study]4.5272630
GSM549125patient 011, cancer, homogenized [OPG study]4.1319719
GSM549127patient 024, cancer, homogenized [OPG study]3.90414
GSM549135patient 035, cancer, homogenized [OPG study]5.6804653